Old Web
English
Sign In
Acemap
>
authorDetail
>
John J. Talley
John J. Talley
Pfizer
COX-2 inhibitor
Stereochemistry
Cyclooxygenase
Benzopyran
Chemistry
3
Papers
247
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life.
2010
Bioorganic & Medicinal Chemistry Letters
Jane L. Wang
David C. Limburg
Matthew J. Graneto
John Robert Springer
Joseph Rogier Bruce Hamper
Subo Liao
Jennifer L. Pawlitz
Ravi G. Kurumbail
Timothy J. Maziasz
John J. Talley
James R. Kiefer
Jeffery Carter
Show All
Source
Cite
Save
Citations (178)
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates
2010
Bioorganic & Medicinal Chemistry Letters
Jane L. Wang
Karl W. Aston
David C. Limburg
Cindy L. Ludwig
Ann E. Hallinan
Francis Koszyk
Bruce C. Hamper
David Brown
Matthew J. Graneto
John J. Talley
Timothy J. Maziasz
Jaime L. Masferrer
Jeffery Carter
Show All
Source
Cite
Save
Citations (32)
The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate
2010
Bioorganic & Medicinal Chemistry Letters
Jane L. Wang
Jeffery Carter
James R. Kiefer
Ravi G. Kurumbail
Jennifer L. Pawlitz
David Brown
Susan J. Hartmann
Matthew J. Graneto
Karen Seibert
John J. Talley
Show All
Source
Cite
Save
Citations (37)
1